Skip to main
DLB
DLB logo

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Dolby Laboratories Inc. reported total revenues of $307.0 million, reflecting a year-over-year increase of approximately 1%, and operating margins improved to 33.2%, up from 31.2% in the previous fiscal year. The growth trajectory is supported by an overall revenue increase of 5.9% year-over-year, driven by a 5.6% rise in licensing revenue and a 10% increase in product and service sales, indicating strong adoption of its technologies despite challenging macroeconomic conditions. Furthermore, the expansion of premium large format (PLF) concepts among exhibitors and the growing popularity of Dolby Vision technology in regions like China and India position the company for sustained long-term growth opportunities.

Bears say

Dolby Laboratories Inc. has revised its growth outlook for its Atmos/Vision/Patents business to a range of 15% to 20%, reflecting a slight decline from the previous expectation of 15% to 25%. The company anticipates a high-single-digit revenue decline for fiscal 2026, consistent with a similar decline observed in fiscal 2025, amid continuing headwinds from reduced device volumes stemming from the post-pandemic market. Additionally, gross margins have contracted to 89.7% from 90.1% year-over-year, indicating pressures on profitability while foundational revenue, correlated with device volumes, is also expected to decrease by low-single digits.

Dolby Laboratories (DLB) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 4 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of Dec 18, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $92, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $92, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.